Dapagliflozin and Recurrent Heart Failure Hospitalizations in Heart Failure With Reduced Ejection Fraction: An Analysis of DAPA-HF

Patients with heart failure (HF) and reduced ejection fraction will experience multiple hospitalizations for heart failure during the course of their disease. We assessed the efficacy of dapagliflozin on reducing the rate of total (ie, first and repeat) hospitalizations for heart failure in the DAPA...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Circulation
Hlavní autoři: Jhund, Pardeep S., Ponikowski, Piotr, Docherty, Kieran F., Gasparyan, Samvel B., Böhm, Michael, Chiang, Chern-En, Desai, Akshay S., Howlett, Jonathon, Kitakaze, Masafumi, Petrie, Mark C., Verma, Subodh, Bengtsson, Olof, Langkilde, Anna-Maria, Sjöstrand, Mikaela, Inzucchi, Silvio E., Køber, Lars, Kosiborod, Mikhail N., Martinez, Felipe A., Sabatine, Marc S., Solomon, Scott D., McMurray, John J.V.
Médium: Artigo
Jazyk:Inglês
Vydáno: Lippincott Williams & Wilkins 2021
Témata:
Original Research Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8126492/
https://ncbi.nlm.nih.gov/pubmed/33832352
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCULATIONAHA.121.053659
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky